Literature DB >> 17012107

The metabolic syndrome among postmenopausal women in Ecuador.

Luis A Hidalgo1, Peter A Chedraui, Nancy Morocho, Mariela Alvarado, Diana Chavez, Angelica Huc.   

Abstract

BACKGROUND: The prevalence of the metabolic syndrome increases with age and after the onset of menopause, and may explain in part the apparent acceleration of cardiovascular disease in postmenopausal women.
OBJECTIVE: To determine the prevalence of metabolic syndrome and related risk determinants among postmenopausal women in Ecuador.
METHODS: Postmenopausal women >or=40 years of age, non-users of hormone therapy and with an intact uterus, were asked to participate in a metabolic syndrome screening and educational program at the Institute of Biomedicine of the Universidad Católica of Guayaquil, Ecuador. Sociodemographic data, waist circumference and blood pressure measurements were recorded, and a fasting blood sample obtained for serum glucose and lipid profile determinations. Woman were counseled and managed according to the results. Metabolic syndrome was defined in accordance with the criteria of the Third Adult Treatment Panel (ATP III).
RESULTS: Three hundred and twenty-five postmenopausal women entered the program. Mean (+/-standard deviation) age was 55.9 +/- 8.1 years, 53.5% of them were aged >or=54 years (median). The prevalence of metabolic syndrome, according to ATP III criteria, was 41.5%. Using the same criteria, 38.8%, 16.6%, 56.9% and 54.2% of the women presented with hypertension, diabetes, hypertriglyceridemia and abdominal obesity, respectively. More than 40% of women determined to have hypertension or diabetes lacked knowing so. Logistic regression analysis determined that age increased the risk of presenting hypertension and diabetes (odds ratio (95% confidence interval): 2.0 (1.2-3.2) and 1.6 (0.9-3.0), respectively, p < 0.05), entities which in turn duplicated the risk of having high triglyceride levels. Sedentary women with <5 years since menopause onset were at higher risk of having abdominal obesity, which was directly related to diabetes and hypertension.
CONCLUSIONS: In this postmenopausal Ecuadorian population the prevalence of the metabolic syndrome was high and its determinant factors related to age, time since menopause onset and sedentary habits. Because of the implications for cardiovascular risk, counseling programs directed toward high-risk populations should be encouraged.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012107     DOI: 10.1080/09513590600890272

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  12 in total

1.  Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study.

Authors:  M Farahmand; F Ramezani Tehrani; M Bahri Khomami; M Noroozzadeh; F Azizi
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

2.  Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study.

Authors:  Ramin Heidari; Masoumeh Sadeghi; Mohammad Talaei; Katayoun Rabiei; Noushin Mohammadifard; Nizal Sarrafzadegan
Journal:  Diabetol Metab Syndr       Date:  2010-10-05       Impact factor: 3.320

3.  Associations of the estrogen receptors 1 and 2 gene polymorphisms with the metabolic syndrome in women.

Authors:  Alessandra C Goulart; Robert Y L Zee; Aruna Pradhan; Kathryn M Rexrode
Journal:  Metab Syndr Relat Disord       Date:  2009-04       Impact factor: 1.894

4.  Menopause and metabolic syndrome: A study of 498 urban women from western India.

Authors:  Shefali Pandey; Manisha Srinivas; Shubhada Agashe; Jayashree Joshi; Priti Galvankar; C P Prakasam; Rama Vaidya
Journal:  J Midlife Health       Date:  2010-07

5.  The Metabolic Syndrome among Postmenopausal Women in Gorgan.

Authors:  Abdoljalal Marjani; Sedigheh Moghasemi
Journal:  Int J Endocrinol       Date:  2012-02-15       Impact factor: 3.257

6.  The Control of Hyperglycemia by Estriol and Progesterone in Alloxan induced Type I Diabetes Mellitus Mice Model through Hepatic Insulin Synthesis.

Authors:  Suman Bhattacharya; Sarbashri Bank; Smarajit Maiti; Asru K Sinha
Journal:  Int J Biomed Sci       Date:  2014-03

7.  The prevalence of metabolic syndrome and its predominant components among pre-and postmenopausal Ghanaian women.

Authors:  Fareed Kow Nanse Arthur; Michael Adu-Frimpong; James Osei-Yeboah; Faustina Obu Mensah; Lawrence Owusu
Journal:  BMC Res Notes       Date:  2013-11-08

8.  Estrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China.

Authors:  Lingxia Zhao; Xuemei Fan; Lin Zuo; Qiang Guo; Xiaole Su; Guangxia Xi; Ziyan Zhang; Jianlin Zhang; Guoping Zheng
Journal:  BMC Endocr Disord       Date:  2018-09-14       Impact factor: 2.763

9.  Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.

Authors:  Jorge Escobedo; Herman Schargrodsky; Beatriz Champagne; Honorio Silva; Carlos P Boissonnet; Raul Vinueza; Marta Torres; Rafael Hernandez; Elinor Wilson
Journal:  Cardiovasc Diabetol       Date:  2009-09-26       Impact factor: 9.951

10.  Metabolic syndrome and menopause.

Authors:  Zahra Jouyandeh; Farnaz Nayebzadeh; Mostafa Qorbani; Mojgan Asadi
Journal:  J Diabetes Metab Disord       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.